MAPT promoter CpG island hypermethylation is associated with poor prognosis in patients with stage II colorectal cancer

References

• Global Burden of Disease Cancer C, Fitzmaurice C, Allen C, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 Cancer Groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3:524–548. doi:10.1001/jamaoncol.2016.568827918777
   PubMed Web of Science ®Google Scholar
• Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci. 1999;96:8681–8686. doi:10.1073/pnas.96.15.868110411935
   PubMed Web of Science ®Google Scholar
• Berman BP, Weisenberger DJ, Aman JF, et al. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet. 2011;44:40–46. doi:10.1038/ng.96922120008
   PubMed Web of Science ®Google Scholar
• Neve RL, Harris P, Kosik KS, Kurnit DM, Donlon TA. Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2. Brain Res. 1986;387:271–280. doi:10.1016/0169-328x(86)90033-13103857
   PubMed Web of Science ®Google Scholar
• Arendt T, Stieler JT, Holzer M. Tau and tauopathies. Brain Res Bull. 2016;126:238–292. doi:10.1016/j.brainresbull.2016.08.01827615390
   PubMed Web of Science ®Google Scholar
• Drubin DG, Kirschner MW. Tau protein function in living cells. J Cell Bio. 1986;103:2739–2746. doi:10.1083/jcb.103.6.27393098742
   PubMed Web of Science ®Google Scholar
• Yu JZ, Rasenick MM. Tau associates with actin in differentiating PC12 cells. Faseb J. 2006;20:1452–1461. doi:10.1096/fj.05-5206com16816120
   PubMed Web of Science ®Google Scholar
• Iwata A, Nagata K, Hatsuta H, et al. Altered CpG methylation in sporadic Alzheimer’s disease is associated with APP and MAPT dysregulation. Hum Mol Genet. 2014;23:648–656. doi:10.1093/hmg/ddt45124101602
   PubMed Web of Science ®Google Scholar
• Coupland KG, Mellick GD, Silburn PA, et al. DNA methylation of the MAPT gene in Parkinson’s disease cohorts and modulation by vitamin E in vitro. Mov Disord. 2014;29:1606–1614. doi:10.1002/mds.2578424375821
   PubMed Web of Science ®Google Scholar
• Shui IM, Wong CJ, Zhao S, et al. Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes. Cancer. 2016;122:2168–2177. doi:10.1002/cncr.3004527142338
   PubMed Web of Science ®Google Scholar
• Brandes JC, Carraway H, Herman JG. Optimal primer design using the novel primer design program: mSPprimer provides accurate methylation analysis of the ATM promoter. Oncogene. 2007;26:6229–6237. doi:10.1038/sj.onc.121043317384671
   PubMed Web of Science ®Google Scholar
• Weisenberger DJ, Siegmund KD, Campan M, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet. 2006;38:787–793. doi:10.1038/ng183416804544
   PubMed Web of Science ®Google Scholar
• Fu T, Pappou EP, Guzzetta AA, et al. CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosis. Clin Cancer Res. 2012;18:4743–4752. doi:10.1158/1078-0432.CCR-12-070722825585
   PubMed Web of Science ®Google Scholar
• Pusztai L, Jeong JH, Gong Y, et al. Evaluation of microtubule-associated protein-tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial. J Clin Oncol. 2009;27:4287–4292. doi:10.1200/JCO.2008.21.688719667268
   PubMed Web of Science ®Google Scholar
• Hristodorov D, Mladenov R, Pardo A, et al. Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo. Br J Cancer. 2013;109:1570–1578. doi:10.1038/bjc.2013.45723942071
   PubMed Web of Science ®Google Scholar
• Hristodorov D, Nordlohne J, Mladenov R, et al. Human microtubule-associated protein tau mediates targeted killing of CD30(+) lymphoma cells in vitro and inhibits tumour growth in vivo. Br J Haematol. 2014;164:251–257. doi:10.1111/bjh.1262624164493
   PubMed Web of Science ®Google Scholar
• Matrone MA, Whipple RA, Thompson K, et al. Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells. Oncogene. 2010;29:3217–3227. doi:10.1038/onc.2010.6820228842
   PubMed Web of Science ®Google Scholar
• Drechsel DN, Hyman AA, Cobb MH, Kirschner MW. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Bio Cell. 1992;3:1141–1154. doi:10.1091/mbc.3.10.11411421571
   PubMed Web of Science ®Google Scholar
• Rossi G, Dalpra L, Crosti F, et al. A new function of microtubule-associated protein tau: involvement in chromosome stability. Cell Cycle. 2008;7:1788–1794. doi:10.4161/cc.7.12.601218583940
   PubMed Web of Science ®Google Scholar
• Violet M, Delattre L, Tardivel M, et al. A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions. Front Cell Neurosci. 2014;8:84. doi:10.3389/fncel.2014.0005224672431
   PubMed Web of Science ®Google Scholar
• Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. Embo J. 1989;8:393–399.2498079
   PubMed Web of Science ®Google Scholar
• Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc Natl Acad Sci. 1988;85:4051–4055. doi:10.1073/pnas.85.11.40513131773
   PubMed Web of Science ®Google Scholar
• Sergeant N, Delacourte A, Buee L. Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta. 2005;1739:179–197. doi:10.1016/j.bbadis.2004.06.02015615637
   PubMed Web of Science ®Google Scholar
• Dugger BN, Whiteside CM, Maarouf CL, et al. The presence of select tau species in human peripheral tissues and their relation to Alzheimer’s disease. J Alzheimer’s Dis. 2016;54:1249. doi:10.3233/JAD-16900727716678
   PubMed Web of Science ®Google Scholar